HER2 overexpression/amplification status in colorectal cancer: a comparison between immunohistochemistry and fluorescence in situ hybridization using five different immunohistochemical scoring criteria

OBJECTIVE: Although HER2 has gradually become an important therapeutic target for colorectal cancer (CRC), a unified and standard HER2 scoring system was still not established in CRC, and the debatable results of immunohistochemistry and fluorescence in situ hybridization (FISH) in CRC requires furt...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Qi, Li, Qi, Gao, Fuping, Wu, Hongyan, Fu, Yao, Yang, Jun, Fan, Xiangshan, Cui, Xiaobin, Pu, Xiaohong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article – Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931822/
https://www.ncbi.nlm.nih.gov/pubmed/36018511
http://dx.doi.org/10.1007/s00432-022-04230-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931822/
https://www.ncbi.nlm.nih.gov/pubmed/36018511
http://dx.doi.org/10.1007/s00432-022-04230-8

Ejemplares similares